Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin

Background and aim. In patients with chronic hepatitis C receiving Peg interferon/ribavirin (PEG-IFN/RBV) who do not achieve ≥ 2log-reduction in HCV-RNA at week 12 (null responders, NR) and in those with ≥ 2log-decrease but detectable at week 24 (partial responders, PR) the probability to achieve th...

Descripció completa

Dades bibliogràfiques

Autors principals:	Fabio Conti, Ranka Vukotic, Stefania Lorenzini, Anna Riili, Carmela Cursaro, Alessandra Scuteri, Elisabetta Loggi, Silvia Galli, Giuliano Furlini, Mauro Bernardi, Pietro Andreone, MD.
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2014-03-01
Col·lecció:	Annals of Hepatology
Matèries:	Hepatitis C Genotype 1 Antiviral treatment High ribavirin dose Partial responder
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1665268119308828
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!